Hyperprolactinemia: pathophysiology and therapeutic approach

References

• Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:273–88
   PubMed Web of Science ®Google Scholar
• Freeman ME, Kanyicska B, Lenart A, Nagy G. Prolactin: structure, function and regulation of secretion. Physiol Rev 2000;80:1523–631
   PubMed Web of Science ®Google Scholar
• Colao A. Pituitary tumours: the prolactinoma. Best Pract Res Clin Endocrinol Metab 2009;23:575–96
   PubMed Web of Science ®Google Scholar
• Ignacak A, Kasztelnik M, Sliwa T. Prolactin – not only lactotrophin. A “new” view of the “old” hormone. J Physiol Pharmacol 2012;63:435–43
   PubMed Web of Science ®Google Scholar
• Prabhakar VK, Davis JR. Hyperprolactinaemia. Best Pract Res Clin Obstet Gynaecol 2008;22:341–53
   PubMed Web of Science ®Google Scholar
• Torre DL, Falorni A. Pharmacological causes of hyperprolactinemia. Ther Clin Risk Manag 2007;3:929–51
   PubMedGoogle Scholar
• Sinha YN. Structural variants of prolactin: occurrence and physiological significance. Endocr Rev 1995;16:354–69
   PubMed Web of Science ®Google Scholar
• Adamson AD, Fieddrichsen S, Semprini S, et al. Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-a signaling. Endocrinology 2007;149:687–94
   PubMed Web of Science ®Google Scholar
• Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990;87:6934–8
   PubMed Web of Science ®Google Scholar
• Chahal J, Schlechte J. Hyperprolactinemia. Pituitary 2008;11:141–6
   PubMed Web of Science ®Google Scholar
• Devi Y, Halperin J. Reproductive actions of prolactin mediated through short and long receptor isoforms. Mol Cell Endocrinol 2014;382:400–10
   PubMed Web of Science ®Google Scholar
• Bouilly J, Sonigo C, Auffret J, et al. Prolactin signaling mechanisms in ovary. Mol Cell Endocrinol 2012;356:80–7
   PubMed Web of Science ®Google Scholar
• Park S, Kim da S, Daily JW, Kim SH. Serum prolactin concentrations determine whether they improve or impair β-cell function and insulin sensitivity in diabetic rats. Diabetes Metab Res Rev 2011;27:564–74
   PubMed Web of Science ®Google Scholar
• Glasow A, Breidert M, Haidan A. Functional aspects of the effect of prolactin (PRL) on adrenal steroidogenesis and distribution of the PRL receptor in the human adrenal gland. J Clin Endocrinol Metab 1996;81:3103–11
   PubMed Web of Science ®Google Scholar
• Molinari C, Grossini E, Mary DA, et al. Prolactin induces regional vasoconstriction through beta-2-adrenergic and nitric oxide mechanisms. Endocrinology 2007;148:4080–90
   PubMed Web of Science ®Google Scholar
• Zhang L, Curhan GC, Forman JP. Plasma prolactin level and risk of incident hypertension in postmenopausal women. J Hypertens 2010;28:1400–5
   PubMed Web of Science ®Google Scholar
• Leanos-Miranda A, Marquez-Acosta J, Cardenas-Mondragon GM, et al. Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes. J Clin Endocrinol Metab 2008;93:2492–9
   PubMed Web of Science ®Google Scholar
• McClure CK, Catov JM, Ness RB, Schwarz EB. Lactation and maternal subclinical cardiovascular disease among premenopausal women. Am J Obstet Gynecol 2012;207:46.e1–8
   PubMed Web of Science ®Google Scholar
• Georgiopoulos GA, Stamatelopoulos KS, Lambrinoudaki I, et al. Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors. Hypertension 2009;54:98–105
   PubMed Web of Science ®Google Scholar
• Carrero JJ, Kyriazis J, Sonmez A. Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD. Clin J Am Soc Nephrol 2012;7:207–15
   PubMed Web of Science ®Google Scholar
• Pathipati P, Gorba T, Scheepens A, et al. Growth hormone and prolactin regulate human neural stem cell regenerative activity. Neuroscience 2011;190:409–27
   PubMed Web of Science ®Google Scholar
• Chavez-Rueda K, Hernandez J, Zenteno E, Leanos-Miranda A. Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes. Clin Immunol 2005;116:182–91
   PubMed Web of Science ®Google Scholar
• Zoli A, Lizzio MM, Ferlisi EM, et al. ACTH, cortisol and prolactin in active rheumatoid arthritis. Clin Rheumatol 2002;21:289–93
   PubMed Web of Science ®Google Scholar
• Imrich R. The role of neuroendocrine system in the pathogenesis of rheumatic diseases. Endocr Regul 2002;36:95–106
   PubMedGoogle Scholar
• Breves JP, Serizier SB, Goffin V. Prolactin regulates transcription of the ion uptake Na+/Cl− cotransporter (ncc) gene in zebrafish gill. Mol Cell Endocrinol 2013;369:98–106
   PubMed Web of Science ®Google Scholar
• Clendenen TV, Arslan AA, Lokshin AE. Circulating prolactin levels and risk of epithelial ovarian cancer. Cancer Causes Control 2013;24:741–8
   PubMed Web of Science ®Google Scholar
• Tworoger SS, Eliassen AH, Rosner B, et al. Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 2004;64:6814–9
   PubMed Web of Science ®Google Scholar
• Kindblom J, Dillner K, Sahlin L, et al. Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin. Endocrinology 2003;144:2269–78
   PubMed Web of Science ®Google Scholar
• Dilmé-Carreras E, Martın-Ezquerra G, Sánchez-Regaña M, et al. Serum prolactin levels in psoriasis and correlation with cutaneous disease activity. Clin Exp Dermatol 2011;36:29–32
   PubMed Web of Science ®Google Scholar
• Madhusoodanan S, Parida S, Jimenez C. Hyperprolactinemia associated with psychotropics – a review. Hum Psychopharmacol 2010;25:281–97
   PubMed Web of Science ®Google Scholar
• Robin G, Catteau-Jonard S, Young J. Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: myth or reality? Gynecol Obstet Fertil 2011;39:141–5
   PubMed Web of Science ®Google Scholar
• Cortet-Rudelli C, Sapin R, Bonnecille JF, Brune T. Etiological diagnosis of hyperprolactinemia. Ann Endocrinol (Paris) 2007;68:98–105
   PubMed Web of Science ®Google Scholar
• Verhelst J, Abs R. Hyperprolactinemia: pathophysiology and management. Treat Endocrinol 2003;2:23–32
   PubMedGoogle Scholar
• Vergés B, Boureille F, Goudet P, et al. Pituitary disease in MEN type 1 [MEN1]: data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 2002;87:457–65
   PubMed Web of Science ®Google Scholar
• Shimatsu A, Hattori N. Macroprolactinemia: diagnostic, clinical, and pathogenic significance. Clin Dev Immunol 2012;2012:167132
   PubMedGoogle Scholar
• Galdiero M, Pivonello R, Grasso LF. Growth hormone, prolactin, and sexuality. J Endocrinol Invest 2012;35:782–94
   PubMed Web of Science ®Google Scholar
• Mazziotti G, Porcelli T, Giustina A. Vertebral fractures in males with prolactinoma. Endocrine 2011;39:288–93
   PubMed Web of Science ®Google Scholar
• Mancini T, Casanueva FF, Giustina A. Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North Am 2008;37:67–9
   PubMed Web of Science ®Google Scholar
• Crosignani PG. Current treatment issues in female hyperprolactinaemia. Eur J Obstet Gynecol Reprod Biol 2006;125:152–64
   PubMed Web of Science ®Google Scholar
• Colao A, Savastano S. Medical treatment of prolactinomas. Nat Rev Endocrinol 2011;7:267–78
   PubMed Web of Science ®Google Scholar